Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood imm...
Saved in:
Published in | Nature immunology Vol. 19; no. 6; pp. 617 - 624 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.06.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM
+
) and IgA
+
memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of
Klebsiella pneumoniae
, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant
K. pneumoniae
serotypes. However, cross-specificity was not limited to
K. pneumoniae
, as
K. pneumonia
e–specific antibodies recognized diverse intestinal microbes and neutralized not only
K. pneumoniae
LPS but also non–
K. pneumoniae
LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.
Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell–independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific ‘affinity-matured’ antibodies to the O antigen of Klebsiella lipopolysaccharides. |
---|---|
AbstractList | Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM ) and IgA memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae–specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non–K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM.sup.+) and IgA.sup.+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell-independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific 'affinity-matured' antibodies to the O antigen of Klebsiella lipopolysaccharides. Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM.sup.+) and IgA.sup.+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M–positive (IgM + ) and IgA + memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae , an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae , as K. pneumonia e–specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non– K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies. Carbohydrate-specific antibodies are typically thought to be of low affinity and produced by T cell–independent pathways. Wardemann and colleagues identify human memory B cells that can produce specific ‘affinity-matured’ antibodies to the O antigen of Klebsiella lipopolysaccharides. |
Audience | Academic |
Author | Klein, Sabrina Hoffmann, Peter Lukasiewicz, Jolanta Stojkovic, Katarina Kocher, Simone von Frankenberg, Moritz Hartl, Katharina Heeg, Klaus Nagy, Gabor Lasitschka, Felix Schröder-Braunstein, Jutta Szijarto, Valeria Gaebelein, Gereon Al-Saeedi, Mohammed Nagy, Eszter Stulik, Lukas Rollenske, Tim Wardemann, Hedda Guachalla, Luis M. |
Author_xml | – sequence: 1 givenname: Tim surname: Rollenske fullname: Rollenske, Tim organization: Max Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Division of B Cell Immunology, German Cancer Research Center – sequence: 2 givenname: Valeria surname: Szijarto fullname: Szijarto, Valeria organization: Arsanis Biosciences – sequence: 3 givenname: Jolanta surname: Lukasiewicz fullname: Lukasiewicz, Jolanta organization: Department of Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences – sequence: 4 givenname: Luis M. orcidid: 0000-0003-1152-9930 surname: Guachalla fullname: Guachalla, Luis M. organization: Arsanis Biosciences – sequence: 5 givenname: Katarina surname: Stojkovic fullname: Stojkovic, Katarina organization: Department of Immunochemistry, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy of Sciences – sequence: 6 givenname: Katharina surname: Hartl fullname: Hartl, Katharina organization: Arsanis Biosciences – sequence: 7 givenname: Lukas surname: Stulik fullname: Stulik, Lukas organization: Arsanis Biosciences – sequence: 8 givenname: Simone surname: Kocher fullname: Kocher, Simone organization: Division of B Cell Immunology, German Cancer Research Center – sequence: 9 givenname: Felix orcidid: 0000-0002-3212-1881 surname: Lasitschka fullname: Lasitschka, Felix organization: Institute of Pathology, University Hospital Heidelberg – sequence: 10 givenname: Mohammed surname: Al-Saeedi fullname: Al-Saeedi, Mohammed organization: Department of General and Transplant Surgery, University Hospital Heidelberg – sequence: 11 givenname: Jutta surname: Schröder-Braunstein fullname: Schröder-Braunstein, Jutta organization: Institute of Immunology, University Hospital Heidelberg – sequence: 12 givenname: Moritz surname: von Frankenberg fullname: von Frankenberg, Moritz organization: Department of General, Abdominal and Minimal Invasive Surgery, Hospital Salem – sequence: 13 givenname: Gereon surname: Gaebelein fullname: Gaebelein, Gereon organization: Department of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Department of General, Visceral, Vascular and Pediatric Surgery, Saarland University Medical Center – sequence: 14 givenname: Peter surname: Hoffmann fullname: Hoffmann, Peter organization: Department of Gastroenterology, University Hospital Heidelberg – sequence: 15 givenname: Sabrina surname: Klein fullname: Klein, Sabrina organization: Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg – sequence: 16 givenname: Klaus surname: Heeg fullname: Heeg, Klaus organization: Department of Infectious Diseases, Medical Microbiology and Hygiene, University Hospital Heidelberg – sequence: 17 givenname: Eszter surname: Nagy fullname: Nagy, Eszter organization: Arsanis Biosciences – sequence: 18 givenname: Gabor surname: Nagy fullname: Nagy, Gabor organization: Arsanis Biosciences – sequence: 19 givenname: Hedda orcidid: 0000-0003-3921-5933 surname: Wardemann fullname: Wardemann, Hedda email: h.wardemann@dkfz.de organization: Max Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Division of B Cell Immunology, German Cancer Research Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29760533$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt1r1TAYxoNsuC__AG8k4I1edOajSZrLcZg6dmDi5p0Q0vZtzWjTY5KK--9NPXPjDJUQEsLvefMkz3uE9vzkAaGXlJxSwqt3saRCk4LQKk8iC_YMHVLBdME0lXsPe1IdoKMYbwmhpZLlc3TAtJJEcH6Ivq7CFGMRN9C4zjUu3eGpw5swJWiS-wH42zxaj61Prp5aBxHb3jofE74coI4OhsHijYd5nLyzgNefrvFVseA9-BO039khwov79Rh9eX9-s_pYrK8-XKzO1kUjuE6F4qUSkmqQXJO2VFprSksqK8VrC5Iw0VnOBas1p1xmoq00Y5y3gnb5RYwfozfbutn39xliMqOLzWLNwzRHwwjXrMplRUZfP0Fvpzn47C5TJVOsklo-Ur0dwDjfTSnYZilqzoRiQqjyN3X6FyqPFkbX5Kg6l893BG93BJlJ8DP1do7RXFx_3mVf3Rud6xFaswlutOHO_IkuA3QLNEuCAboHhBKztIfZtofJ7WGW9jDLR6knmpy4TS77CNYN_1WyrTLmW3wP4fHf_i36BXBxyL4 |
CitedBy_id | crossref_primary_10_1039_D3OB01203D crossref_primary_10_1128_IAI_00412_21 crossref_primary_10_1007_s00253_022_11989_w crossref_primary_10_1128_mSphere_01335_20 crossref_primary_10_3390_vaccines10111789 crossref_primary_10_1172_JCI122032 crossref_primary_10_2147_IDR_S338987 crossref_primary_10_1084_jem_20200275 crossref_primary_10_1093_infdis_jiae097 crossref_primary_10_1016_j_carres_2023_108807 crossref_primary_10_1007_s00018_018_2976_8 crossref_primary_10_1038_s41385_019_0223_8 crossref_primary_10_1038_s41385_019_0227_4 crossref_primary_10_1038_s41586_021_03973_7 crossref_primary_10_1126_sciadv_ado9455 crossref_primary_10_1016_j_immuni_2023_08_018 crossref_primary_10_1146_annurev_immunol_042718_041238 crossref_primary_10_3389_fmolb_2021_719396 crossref_primary_10_1084_jem_20180977 crossref_primary_10_1038_s41385_018_0120_6 crossref_primary_10_1002_adfm_202001232 crossref_primary_10_1016_j_celrep_2019_03_032 crossref_primary_10_1016_j_jim_2020_112752 crossref_primary_10_1038_s41575_022_00674_y crossref_primary_10_1097_BOR_0000000000000574 crossref_primary_10_1021_acscatal_0c05378 crossref_primary_10_1038_s41467_024_52372_9 crossref_primary_10_1039_C8LC01310A crossref_primary_10_1016_j_vetmic_2022_109361 crossref_primary_10_1002_1873_3468_14347 crossref_primary_10_1097_QCO_0000000000000539 crossref_primary_10_3389_fimmu_2020_595535 crossref_primary_10_3389_fmicb_2022_880484 crossref_primary_10_3390_ijms25105487 crossref_primary_10_1093_intimm_dxab109 crossref_primary_10_2745_dds_37_395 crossref_primary_10_1093_intimm_dxab066 crossref_primary_10_1126_sciadv_abf6834 crossref_primary_10_1016_j_cell_2023_10_002 crossref_primary_10_1111_imr_13014 crossref_primary_10_1084_jem_20181635 crossref_primary_10_1371_journal_pmed_1004239 crossref_primary_10_15252_emmm_202115386 crossref_primary_10_1016_j_csbj_2019_09_011 crossref_primary_10_1016_j_carbpol_2023_121581 crossref_primary_10_1042_BCJ20200610 crossref_primary_10_1016_j_lanmic_2024_100988 crossref_primary_10_1093_pnasnexus_pgad310 crossref_primary_10_3390_ijms21186572 crossref_primary_10_1016_j_jaci_2018_09_036 crossref_primary_10_1021_acsabm_9b00936 crossref_primary_10_1128_mmbr_00045_22 crossref_primary_10_1038_s41385_022_00539_2 crossref_primary_10_1084_jem_20220839 crossref_primary_10_3390_vaccines12101177 crossref_primary_10_3390_ijms22084042 crossref_primary_10_1128_mmbr_00090_23 crossref_primary_10_1016_j_it_2024_01_006 crossref_primary_10_1038_s41590_020_00856_3 crossref_primary_10_1016_j_jbc_2024_107420 crossref_primary_10_1016_j_micres_2025_128083 crossref_primary_10_1080_14760584_2019_1635460 crossref_primary_10_1038_s41385_019_0192_y crossref_primary_10_1242_dmm_043240 crossref_primary_10_1002_ejoc_201900389 crossref_primary_10_1371_journal_pone_0203143 crossref_primary_10_1126_sciimmunol_abc7191 crossref_primary_10_1126_sciimmunol_abg3208 crossref_primary_10_17816_MAJ633511 crossref_primary_10_3390_ijms22168896 crossref_primary_10_1128_spectrum_00400_24 crossref_primary_10_1038_s41598_023_39613_5 crossref_primary_10_3389_fimmu_2023_1193855 crossref_primary_10_3390_diagnostics13152490 crossref_primary_10_1016_j_celrep_2022_110611 crossref_primary_10_1016_j_mimet_2023_106730 crossref_primary_10_3389_fimmu_2020_573629 crossref_primary_10_1212_NXI_0000000000000997 crossref_primary_10_1099_mgen_0_000433 crossref_primary_10_3389_fimmu_2020_01755 crossref_primary_10_1038_s41577_019_0261_1 crossref_primary_10_3389_fmolb_2021_666756 crossref_primary_10_1038_s41564_024_01612_1 crossref_primary_10_1073_pnas_2301302120 crossref_primary_10_1016_j_coi_2019_09_003 crossref_primary_10_1016_j_mib_2020_08_003 crossref_primary_10_1016_j_immuni_2018_08_011 crossref_primary_10_1016_j_it_2023_08_005 crossref_primary_10_3389_fimmu_2018_03064 crossref_primary_10_1038_s41590_018_0216_x crossref_primary_10_1038_s42003_021_02714_w crossref_primary_10_3390_vaccines8010013 crossref_primary_10_1152_ajplung_00377_2023 crossref_primary_10_1038_s41589_020_0494_0 crossref_primary_10_1038_s41435_020_0105_9 crossref_primary_10_3389_fimmu_2024_1404192 crossref_primary_10_1080_19420862_2021_2006123 crossref_primary_10_1128_msphere_00680_22 crossref_primary_10_1126_scitranslmed_abl3927 |
Cites_doi | 10.1172/JCI44447 10.1186/1471-2105-13-31 10.1038/35098100 10.1093/bioinformatics/btu393 10.1038/ni.3213 10.1002/eji.201545526 10.1016/S0264-410X(98)00139-X 10.1074/jbc.M202683200 10.1099/mgen.0.000073 10.1038/nmeth.f.303 10.1038/mi.2012.56 10.1126/science.1086907 10.1016/j.chom.2007.01.002 10.1038/nature07830 10.1016/j.jim.2007.09.017 10.3389/fmicb.2017.00684 10.1016/j.chom.2014.07.003 10.1099/00221287-12-2-367 10.1073/pnas.0700630104 10.1016/j.ijmm.2015.12.002 10.1038/nri.2016.114 10.1080/21505594.2017.1279778 10.1016/j.immuni.2015.06.013 10.1016/j.it.2015.06.006 10.1128/AAC.04494-14 10.1016/j.immuni.2017.06.013 10.1128/CMR.11.4.589 10.1007/s00281-004-0182-2 10.1016/j.chom.2007.09.013 10.1016/j.jim.2015.04.010 10.1016/j.immuni.2007.01.009 10.1111/febs.13530 10.1172/JCI91192 10.1186/s12859-016-0920-1 10.1084/jem.57.4.571 10.1084/jem.20161590 10.1128/jb.173.4.1420-1431.1991 10.1016/S0008-6215(00)90412-9 10.1146/annurev.iy.13.040195.003255 10.1084/jem.20011112 10.1126/science.aan6619 10.1007/978-0-387-98141-3 10.1084/jem.44.5.683 10.1038/s41598-017-06682-2 10.7883/yoken.JJID.2014.051 10.1084/jem.50.5.551 10.1128/JB.180.15.3735-3740.1998 10.1128/JCM.37.1.56-62.1999 10.1128/CDLI.4.5.550-555.1997 |
ContentType | Journal Article |
Copyright | The Author(s) 2018 COPYRIGHT 2018 Nature Publishing Group Copyright Nature Publishing Group Jun 2018 |
Copyright_xml | – notice: The Author(s) 2018 – notice: COPYRIGHT 2018 Nature Publishing Group – notice: Copyright Nature Publishing Group Jun 2018 |
DBID | AAYXX CITATION NPM ISR 3V. 7QP 7QR 7T5 7TK 7TM 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 |
DOI | 10.1038/s41590-018-0106-2 |
DatabaseName | CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Public Health ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1529-2916 |
EndPage | 624 |
ExternalDocumentID | A572557496 29760533 10_1038_s41590_018_0106_2 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 0R~ 123 29M 2FS 36B 39C 3V. 4.4 53G 5BI 5RE 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAEEF AAHBH AARCD AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABNNU ABOCM ABUWG ACBWK ACGFS ACIWK ACPRK ACRPL ACUHS ADBBV ADNMO AENEX AEUYN AFBBN AFKRA AFRAH AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EAS EBS EE. EJD EMB EMK EMOBN ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ISR ITC L-9 LK8 M1P M7P N9A NNMJJ O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WH7 X7M Y6R ZXP AAYXX AFANA ALPWD ATHPR CITATION PHGZM PHGZT NPM PMFND 7QP 7QR 7T5 7TK 7TM 7U9 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 7X8 |
ID | FETCH-LOGICAL-c539t-73475619e6390d4799911416873bae6025fa3352b931360d4d892233d51f14723 |
IEDL.DBID | 7X7 |
ISSN | 1529-2908 1529-2916 |
IngestDate | Mon Jul 21 11:20:33 EDT 2025 Fri Jul 25 09:08:56 EDT 2025 Tue Jun 17 21:45:12 EDT 2025 Tue Jun 10 20:24:04 EDT 2025 Fri Jun 27 05:08:28 EDT 2025 Wed Feb 19 02:32:19 EST 2025 Thu Apr 24 22:54:04 EDT 2025 Tue Jul 01 03:07:11 EDT 2025 Fri Feb 21 02:38:57 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c539t-73475619e6390d4799911416873bae6025fa3352b931360d4d892233d51f14723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1152-9930 0000-0002-3212-1881 0000-0003-3921-5933 |
PMID | 29760533 |
PQID | 2042728696 |
PQPubID | 45782 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2039289995 proquest_journals_2042728696 gale_infotracmisc_A572557496 gale_infotracacademiconefile_A572557496 gale_incontextgauss_ISR_A572557496 pubmed_primary_29760533 crossref_primary_10_1038_s41590_018_0106_2 crossref_citationtrail_10_1038_s41590_018_0106_2 springer_journals_10_1038_s41590_018_0106_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-06-01 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: 2018-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Nature immunology |
PublicationTitleAbbrev | Nat Immunol |
PublicationTitleAlternate | Nat Immunol |
PublicationYear | 2018 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | Tillett, Avery, Goebel (CR4) 1929; 50 Landsverk (CR32) 2017; 214 Tiller (CR38) 2008; 329 Trautmann (CR6) 1997; 4 Podschun, Ullmann (CR9) 1998; 11 Guachalla (CR18) 2017; 7 Zhou (CR25) 2007; 1 Baumgarth, Tung, Herzenberg (CR31) 2005; 26 Toellner (CR14) 2002; 195 Hansen (CR7) 1999; 37 Wickham (CR50) 2009 Tiller (CR36) 2007; 26 Szijártó (CR44) 2017; 8 Bunker (CR13) 2017; 358 Stojkovic (CR17) 2017; 8 Lorin, Mouquet (CR40) 2015; 422 CR47 Vinogradov (CR5) 2002; 277 Bergqvist (CR29) 2013; 6 Gu, Gu, Eils, Schlesner, Brors (CR51) 2014; 30 Cerca (CR43) 2007; 104 Mond, Lees, Snapper (CR11) 1995; 13 Lipke, Ovalle (CR21) 1998; 180 Julianelle (CR1) 1926; 44 Lindner (CR28) 2015; 16 Szijártó (CR42) 2015; 59 Polonskaya (CR26) 2017; 127 Masella, Bartram, Truszkowski, Brown, Neufeld (CR45) 2012; 13 Trama (CR23) 2014; 16 Fagarasan, Kinoshita, Muramatsu, Ikuta, Honjo (CR27) 2001; 413 Wardemann (CR41) 2003; 301 Whitfield, Richards, Perry, Clarke, MacLean (CR15) 1991; 173 Doores (CR22) 2015; 282 Bayhan, Senel, Tanir, Ozkan (CR24) 2015; 68 Caporaso (CR46) 2010; 7 Macpherson, Köller, McCoy (CR33) 2015; 36 Di Niro (CR30) 2015; 43 Murugan, Imkeller, Busse, Wardemann (CR39) 2015; 45 Szijártó (CR16) 2016; 306 Imkeller, Arndt, Wardemann, Busse (CR48) 2016; 17 Warnes (CR49) 2009; 2 Follador (CR8) 2016; 2 Magri (CR12) 2017; 47 Lancefield (CR2) 1933; 57 Coughlin (CR34) 1998; 16 Park (CR19) 2009; 458 Benckert (CR37) 2011; 121 Kubinak, Round (CR10) 2016; 16 Peterson, McNulty, Guruge, Gordon (CR35) 2007; 2 Shattock (CR3) 1955; 12 Jansson (CR20) 1985; 145 C Lindner (106_CR28) 2015; 16 R Follador (106_CR8) 2016; 2 R Murugan (106_CR39) 2015; 45 GI Bayhan (106_CR24) 2015; 68 PN Lipke (106_CR21) 1998; 180 T Tiller (106_CR38) 2008; 329 G Magri (106_CR12) 2017; 47 RT Coughlin (106_CR34) 1998; 16 R Niro Di (106_CR30) 2015; 43 KM Toellner (106_CR14) 2002; 195 S Fagarasan (106_CR27) 2001; 413 ZH Zhou (106_CR25) 2007; 1 H Wickham (106_CR50) 2009 K Stojkovic (106_CR17) 2017; 8 J Benckert (106_CR37) 2011; 121 M Trautmann (106_CR6) 1997; 4 AJ Macpherson (106_CR33) 2015; 36 OJB Landsverk (106_CR32) 2017; 214 KJ Doores (106_CR22) 2015; 282 V Szijártó (106_CR42) 2015; 59 JJ Mond (106_CR11) 1995; 13 AM Trama (106_CR23) 2014; 16 JG Caporaso (106_CR46) 2010; 7 AP Masella (106_CR45) 2012; 13 JJ Bunker (106_CR13) 2017; 358 106_CR47 Z Polonskaya (106_CR26) 2017; 127 N Baumgarth (106_CR31) 2005; 26 RC Lancefield (106_CR2) 1933; 57 V Szijártó (106_CR16) 2016; 306 JL Kubinak (106_CR10) 2016; 16 PE Jansson (106_CR20) 1985; 145 V Szijártó (106_CR44) 2017; 8 H Wardemann (106_CR41) 2003; 301 K Imkeller (106_CR48) 2016; 17 T Tiller (106_CR36) 2007; 26 DS Hansen (106_CR7) 1999; 37 WS Tillett (106_CR4) 1929; 50 LM Guachalla (106_CR18) 2017; 7 GR Warnes (106_CR49) 2009; 2 PMF Shattock (106_CR3) 1955; 12 Z Gu (106_CR51) 2014; 30 BS Park (106_CR19) 2009; 458 E Vinogradov (106_CR5) 2002; 277 C Whitfield (106_CR15) 1991; 173 V Lorin (106_CR40) 2015; 422 N Cerca (106_CR43) 2007; 104 P Bergqvist (106_CR29) 2013; 6 R Podschun (106_CR9) 1998; 11 LA Julianelle (106_CR1) 1926; 44 DA Peterson (106_CR35) 2007; 2 29777208 - Nat Immunol. 2018 Jun;19(6):514-515 |
References_xml | – volume: 121 start-page: 1946 year: 2011 end-page: 1955 ident: CR37 article-title: The majority of intestinal IgA and IgG plasmablasts in the human gut are antigen-specific publication-title: J. Clin. Invest. doi: 10.1172/JCI44447 – volume: 13 year: 2012 ident: CR45 article-title: PANDAseq: paired-end assembler for illumina sequences publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-13-31 – volume: 413 start-page: 639 year: 2001 end-page: 643 ident: CR27 article-title: In situ class switching and differentiation to IgA-producing cells in the gut lamina propria publication-title: Nature doi: 10.1038/35098100 – volume: 30 start-page: 2811 year: 2014 end-page: 2812 ident: CR51 article-title: circlize Implements and enhances circular visualization in R publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu393 – volume: 16 start-page: 880 year: 2015 end-page: 888 ident: CR28 article-title: Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota publication-title: Nat. Immunol. doi: 10.1038/ni.3213 – volume: 45 start-page: 2698 year: 2015 end-page: 2700 ident: CR39 article-title: Direct high-throughput amplification and sequencing of immunoglobulin genes from single human B cells publication-title: Eur. J. Immunol. doi: 10.1002/eji.201545526 – volume: 16 start-page: 1761 year: 1998 end-page: 1767 ident: CR34 article-title: Characterization of pneumococcal specific antibodies in healthy unvaccinated adults publication-title: Vaccine doi: 10.1016/S0264-410X(98)00139-X – volume: 277 start-page: 25070 year: 2002 end-page: 25081 ident: CR5 article-title: Structures of lipopolysaccharides from . Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains publication-title: J. Biol. Chem. doi: 10.1074/jbc.M202683200 – volume: 2 start-page: e000073 year: 2016 ident: CR8 article-title: The diversity of surface polysaccharides publication-title: Microb. Genomics doi: 10.1099/mgen.0.000073 – volume: 7 start-page: 335 year: 2010 end-page: 336 ident: CR46 article-title: QIIME allows analysis of high-throughput community sequencing data publication-title: Nat. Methods doi: 10.1038/nmeth.f.303 – volume: 6 start-page: 122 year: 2013 end-page: 135 ident: CR29 article-title: Re-utilization of germinal centers in multiple Peyer’s patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses publication-title: Mucosal Immunol. doi: 10.1038/mi.2012.56 – volume: 301 start-page: 1374 year: 2003 end-page: 1377 ident: CR41 article-title: Predominant autoantibody production by early human B cell precursors publication-title: Science doi: 10.1126/science.1086907 – volume: 1 start-page: 51 year: 2007 end-page: 61 ident: CR25 article-title: The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies publication-title: Cell Host Microbe doi: 10.1016/j.chom.2007.01.002 – volume: 458 start-page: 1191 year: 2009 end-page: 1195 ident: CR19 article-title: The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex publication-title: Nature doi: 10.1038/nature07830 – volume: 329 start-page: 112 year: 2008 end-page: 124 ident: CR38 article-title: Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2007.09.017 – volume: 8 start-page: 684 year: 2017 ident: CR17 article-title: Identification of d-galactan-III as part of the lipopolysaccharide of Serotype O1 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2017.00684 – volume: 16 start-page: 215 year: 2014 end-page: 226 ident: CR23 article-title: HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria publication-title: Cell Host Microbe doi: 10.1016/j.chom.2014.07.003 – volume: 12 start-page: 367 year: 1955 end-page: 374 ident: CR3 article-title: The use of serology in the classification of micro-organisms publication-title: J. Gen. Microbiol. doi: 10.1099/00221287-12-2-367 – volume: 104 start-page: 7528 year: 2007 end-page: 7533 ident: CR43 article-title: Protection against infection by antibody to the poly-N-acetylglucosamine surface polysaccharide publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0700630104 – volume: 306 start-page: 89 year: 2016 end-page: 98 ident: CR16 article-title: Both clades of the epidemic KPC-producing clone ST258 share a modified galactan O-antigen type publication-title: Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2015.12.002 – volume: 16 start-page: 767 year: 2016 end-page: 774 ident: CR10 article-title: Do antibodies select a healthy microbiota? publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2016.114 – volume: 2 start-page: 1 year: 2009 ident: CR49 article-title: Various R programming tools for plotting data publication-title: R package version – volume: 8 start-page: 1203 year: 2017 end-page: 1215 ident: CR44 article-title: Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against ST258 publication-title: Virulence doi: 10.1080/21505594.2017.1279778 – volume: 43 start-page: 120 year: 2015 end-page: 131 ident: CR30 article-title: Salmonella infection drives promiscuous B cell activation followed by extrafollicular affinity maturation publication-title: Immunity doi: 10.1016/j.immuni.2015.06.013 – volume: 36 start-page: 460 year: 2015 end-page: 470 ident: CR33 article-title: The bilateral responsiveness between intestinal microbes and IgA publication-title: Trends Immunol. doi: 10.1016/j.it.2015.06.006 – volume: 59 start-page: 3109 year: 2015 end-page: 3116 ident: CR42 article-title: Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant clone ST131-O25b:H4 elicit protection in mice publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.04494-14 – volume: 47 start-page: 118 year: 2017 end-page: 134 ident: CR12 article-title: Human secretory IgM emerges from plasma cells clonally related to gut memory B cells and targets highly diverse commensals publication-title: Immunity doi: 10.1016/j.immuni.2017.06.013 – volume: 11 start-page: 589 year: 1998 end-page: 603 ident: CR9 article-title: spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.11.4.589 – volume: 26 start-page: 347 year: 2005 end-page: 362 ident: CR31 article-title: Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion publication-title: Springer Semin. Immunopathol. doi: 10.1007/s00281-004-0182-2 – volume: 2 start-page: 328 year: 2007 end-page: 339 ident: CR35 article-title: IgA response to symbiotic bacteria as a mediator of gut homeostasis publication-title: Cell Host Microbe doi: 10.1016/j.chom.2007.09.013 – volume: 37 start-page: 56 year: 1999 end-page: 62 ident: CR7 article-title: lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries publication-title: J. Clin. Microbiol. – ident: CR47 – volume: 422 start-page: 102 year: 2015 end-page: 110 ident: CR40 article-title: Efficient generation of human IgA monoclonal antibodies publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2015.04.010 – volume: 26 start-page: 205 year: 2007 end-page: 213 ident: CR36 article-title: Autoreactivity in human IgG memory B cells publication-title: Immunity doi: 10.1016/j.immuni.2007.01.009 – volume: 282 start-page: 4679 year: 2015 end-page: 4691 ident: CR22 article-title: The HIV glycan shield as a target for broadly neutralizing antibodies publication-title: FEBS J. doi: 10.1111/febs.13530 – volume: 127 start-page: 1491 year: 2017 end-page: 1504 ident: CR26 article-title: T cells control the generation of nanomolar-affinity anti-glycan antibodies publication-title: J. Clin. Invest. doi: 10.1172/JCI91192 – volume: 17 year: 2016 ident: CR48 article-title: sciReptor: analysis of single-cell level immunoglobulin repertoires publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-0920-1 – volume: 57 start-page: 571 year: 1933 end-page: 595 ident: CR2 article-title: A serological differentiation of human and other groups of hemolytic Streptococci publication-title: J. Exp. Med. doi: 10.1084/jem.57.4.571 – volume: 214 start-page: 309 year: 2017 end-page: 317 ident: CR32 article-title: Antibody-secreting plasma cells persist for decades in human intestine publication-title: J. Exp. Med. doi: 10.1084/jem.20161590 – volume: 173 start-page: 1420 year: 1991 end-page: 1431 ident: CR15 article-title: Expression of two structurally distinct D-galactan O antigens in the lipopolysaccharide of serotype O1 publication-title: J. Bacteriol. doi: 10.1128/jb.173.4.1420-1431.1991 – volume: 145 start-page: 59 year: 1985 end-page: 66 ident: CR20 article-title: Structural studies of the O-antigen polysaccharides of Klebsiella O5 and O8 publication-title: Carbohydr. Res. doi: 10.1016/S0008-6215(00)90412-9 – volume: 13 start-page: 655 year: 1995 end-page: 692 ident: CR11 article-title: T cell-independent antigens type 2 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.iy.13.040195.003255 – volume: 195 start-page: 383 year: 2002 end-page: 389 ident: CR14 article-title: Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers publication-title: J. Exp. Med. doi: 10.1084/jem.20011112 – volume: 358 start-page: eaan6619 year: 2017 ident: CR13 article-title: Natural polyreactive IgA antibodies coat the intestinal microbiota publication-title: Science doi: 10.1126/science.aan6619 – year: 2009 ident: CR50 publication-title: ggplot2: Elegant Graphics for Data Analysis doi: 10.1007/978-0-387-98141-3 – volume: 44 start-page: 683 year: 1926 end-page: 696 ident: CR1 article-title: Immunological relationships of encapsulated and capsule-free strains of encapsulated pneumoniae (Friedlander’s Bacillus) publication-title: J. Exp. Med. doi: 10.1084/jem.44.5.683 – volume: 7 year: 2017 ident: CR18 article-title: Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3 publication-title: Sci. Rep. doi: 10.1038/s41598-017-06682-2 – volume: 68 start-page: 50 year: 2015 end-page: 54 ident: CR24 article-title: Bacteremia caused by in pediatric patients publication-title: Jpn. J. Infect. Dis. doi: 10.7883/yoken.JJID.2014.051 – volume: 180 start-page: 3735 year: 1998 end-page: 3740 ident: CR21 article-title: Cell wall architecture in yeast: new structure and new challenges publication-title: J. Bacteriol. – volume: 4 start-page: 550 year: 1997 end-page: 555 ident: CR6 article-title: O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections publication-title: Clin. Diagn. Lab. Immunol. – volume: 50 start-page: 551 year: 1929 end-page: 567 ident: CR4 article-title: Chemo-immunological studies in conjugated carbohydrate-proteins: III. Active and passive anaphylaxis with synthetic sugar-proteins publication-title: J. Exp. Med. doi: 10.1084/jem.50.5.551 – volume: 2 start-page: e000073 year: 2016 ident: 106_CR8 publication-title: Microb. Genomics doi: 10.1099/mgen.0.000073 – volume: 13 start-page: 655 year: 1995 ident: 106_CR11 publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.iy.13.040195.003255 – volume: 2 start-page: 328 year: 2007 ident: 106_CR35 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2007.09.013 – volume: 59 start-page: 3109 year: 2015 ident: 106_CR42 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.04494-14 – volume: 11 start-page: 589 year: 1998 ident: 106_CR9 publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.11.4.589 – volume: 277 start-page: 25070 year: 2002 ident: 106_CR5 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M202683200 – volume: 358 start-page: eaan6619 year: 2017 ident: 106_CR13 publication-title: Science doi: 10.1126/science.aan6619 – ident: 106_CR47 – volume: 26 start-page: 205 year: 2007 ident: 106_CR36 publication-title: Immunity doi: 10.1016/j.immuni.2007.01.009 – volume: 26 start-page: 347 year: 2005 ident: 106_CR31 publication-title: Springer Semin. Immunopathol. doi: 10.1007/s00281-004-0182-2 – volume: 8 start-page: 1203 year: 2017 ident: 106_CR44 publication-title: Virulence doi: 10.1080/21505594.2017.1279778 – volume: 413 start-page: 639 year: 2001 ident: 106_CR27 publication-title: Nature doi: 10.1038/35098100 – volume: 173 start-page: 1420 year: 1991 ident: 106_CR15 publication-title: J. Bacteriol. doi: 10.1128/jb.173.4.1420-1431.1991 – volume: 301 start-page: 1374 year: 2003 ident: 106_CR41 publication-title: Science doi: 10.1126/science.1086907 – volume: 50 start-page: 551 year: 1929 ident: 106_CR4 publication-title: J. Exp. Med. doi: 10.1084/jem.50.5.551 – volume: 68 start-page: 50 year: 2015 ident: 106_CR24 publication-title: Jpn. J. Infect. Dis. doi: 10.7883/yoken.JJID.2014.051 – volume: 16 start-page: 880 year: 2015 ident: 106_CR28 publication-title: Nat. Immunol. doi: 10.1038/ni.3213 – volume: 214 start-page: 309 year: 2017 ident: 106_CR32 publication-title: J. Exp. Med. doi: 10.1084/jem.20161590 – volume: 145 start-page: 59 year: 1985 ident: 106_CR20 publication-title: Carbohydr. Res. doi: 10.1016/S0008-6215(00)90412-9 – volume: 127 start-page: 1491 year: 2017 ident: 106_CR26 publication-title: J. Clin. Invest. doi: 10.1172/JCI91192 – volume: 422 start-page: 102 year: 2015 ident: 106_CR40 publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2015.04.010 – volume: 12 start-page: 367 year: 1955 ident: 106_CR3 publication-title: J. Gen. Microbiol. doi: 10.1099/00221287-12-2-367 – volume: 7 year: 2017 ident: 106_CR18 publication-title: Sci. Rep. doi: 10.1038/s41598-017-06682-2 – volume: 2 start-page: 1 year: 2009 ident: 106_CR49 publication-title: R package version – volume: 6 start-page: 122 year: 2013 ident: 106_CR29 publication-title: Mucosal Immunol. doi: 10.1038/mi.2012.56 – volume: 43 start-page: 120 year: 2015 ident: 106_CR30 publication-title: Immunity doi: 10.1016/j.immuni.2015.06.013 – volume: 306 start-page: 89 year: 2016 ident: 106_CR16 publication-title: Int. J. Med. Microbiol. doi: 10.1016/j.ijmm.2015.12.002 – volume: 17 year: 2016 ident: 106_CR48 publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-0920-1 – volume: 44 start-page: 683 year: 1926 ident: 106_CR1 publication-title: J. Exp. Med. doi: 10.1084/jem.44.5.683 – volume: 180 start-page: 3735 year: 1998 ident: 106_CR21 publication-title: J. Bacteriol. doi: 10.1128/JB.180.15.3735-3740.1998 – volume: 36 start-page: 460 year: 2015 ident: 106_CR33 publication-title: Trends Immunol. doi: 10.1016/j.it.2015.06.006 – volume: 45 start-page: 2698 year: 2015 ident: 106_CR39 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201545526 – volume: 329 start-page: 112 year: 2008 ident: 106_CR38 publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2007.09.017 – volume: 104 start-page: 7528 year: 2007 ident: 106_CR43 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0700630104 – volume: 37 start-page: 56 year: 1999 ident: 106_CR7 publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.37.1.56-62.1999 – volume: 8 start-page: 684 year: 2017 ident: 106_CR17 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2017.00684 – volume: 57 start-page: 571 year: 1933 ident: 106_CR2 publication-title: J. Exp. Med. doi: 10.1084/jem.57.4.571 – volume: 282 start-page: 4679 year: 2015 ident: 106_CR22 publication-title: FEBS J. doi: 10.1111/febs.13530 – volume: 13 year: 2012 ident: 106_CR45 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-13-31 – volume: 30 start-page: 2811 year: 2014 ident: 106_CR51 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu393 – volume: 16 start-page: 215 year: 2014 ident: 106_CR23 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2014.07.003 – volume: 195 start-page: 383 year: 2002 ident: 106_CR14 publication-title: J. Exp. Med. doi: 10.1084/jem.20011112 – volume: 47 start-page: 118 year: 2017 ident: 106_CR12 publication-title: Immunity doi: 10.1016/j.immuni.2017.06.013 – volume: 16 start-page: 767 year: 2016 ident: 106_CR10 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2016.114 – volume-title: ggplot2: Elegant Graphics for Data Analysis year: 2009 ident: 106_CR50 doi: 10.1007/978-0-387-98141-3 – volume: 458 start-page: 1191 year: 2009 ident: 106_CR19 publication-title: Nature doi: 10.1038/nature07830 – volume: 121 start-page: 1946 year: 2011 ident: 106_CR37 publication-title: J. Clin. Invest. doi: 10.1172/JCI44447 – volume: 1 start-page: 51 year: 2007 ident: 106_CR25 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2007.01.002 – volume: 4 start-page: 550 year: 1997 ident: 106_CR6 publication-title: Clin. Diagn. Lab. Immunol. doi: 10.1128/CDLI.4.5.550-555.1997 – volume: 7 start-page: 335 year: 2010 ident: 106_CR46 publication-title: Nat. Methods doi: 10.1038/nmeth.f.303 – volume: 16 start-page: 1761 year: 1998 ident: 106_CR34 publication-title: Vaccine doi: 10.1016/S0264-410X(98)00139-X – reference: 29777208 - Nat Immunol. 2018 Jun;19(6):514-515 |
SSID | ssj0014764 |
Score | 2.5664315 |
Snippet | Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate... |
SourceID | proquest gale pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 617 |
SubjectTerms | 631/250/2152/2153/1291 631/250/2499 631/250/347 Antibiotic resistance Antibodies Antigenic determinants Antigens B cells Bacterial diseases Bacterial infections Biomedical and Life Sciences Biomedicine Drug therapy Epitopes Immune response Immune response (humoral) Immunoglobulin A Immunoglobulin M Immunoglobulins Immunological memory Immunology Infection Infection control Infectious Diseases Intestine Klebsiella infections Klebsiella pneumoniae Lipopolysaccharides Lymphocytes B Memory cells Microbial drug resistance Microbial polysaccharides Microbiota Microbiota (Symbiotic organisms) Microorganisms Mitogens Monoclonal antibodies Nosocomial infection O antigens Opportunist infection Pathogenic microorganisms Pathogens Peripheral blood Pneumonia Polysaccharides Prevention Risk factors Serotypes Surface antigens T cells |
Title | Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen |
URI | https://link.springer.com/article/10.1038/s41590-018-0106-2 https://www.ncbi.nlm.nih.gov/pubmed/29760533 https://www.proquest.com/docview/2042728696 https://www.proquest.com/docview/2039289995 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9wwDBdby8ZextZ9ZeuKNwaDjbDEjmP7aXRHS_fRrrQr3MPAOIlTDkpybe4e9t9PSpzrrrC-BI4oyVmWrJ8sWQJ4V0vujcxKVHHpYrTQqFLCi1gXrspzzeuy37o4PMoPzrJvUzkNG25dSKsc18R-oa7akvbI0UnPuOI6N_nn-WVMXaMouhpaaNyFTSpdRlKtpiuHK81UXz4KTZSJuUn0GNUU-lOHhstQShalcqFTzdfs0s3V-R_zdCNe2puh_UfwMOBHtjtM-GO445stuDd0lPyzBfcPQ6z8Cfye0IdiOkpJ6UCItllbs1CXAdc41rfnY8jZWdFSLiFz526GaJF9v_BFN6O0KDZv_BJHPnOe_Tg-ZT9jIkeZewpn-3u_Jgdx6KUQl1KYRaxEphAqGY-IJKkyRbgwRTCmlSiczxH51I6OXxVGpCJHikobRA6ikmmNfOTiGWw0beNfAHPo13rPEyldju5VbbQqtXL4A92PokwiSEZO2jIUGqd-Fxe2D3gLbQfmW2S-JeZbHsGH1SPzocrGbcRvaXosVa9oKD3m3C27zn49PbG7UqGLpDKTR_A-ENUtfrx04bQBDoEKXq1Rbq9RonqV67dHKbBBvTt7LYwRvFndpidpbhrfLokGoSd6s0ZG8HyQntXYOIJAOgQdwcdRnK5f_t-Bv7z9r7yCB7yXZ9oi2oaNxdXSv0bEtCh2erXAq56kO7D5Ze_o-OQvx9YNlA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw9Gga4vKCYNwCAwwCITFFpHYc2w8ITYWppe1AbJP2gGSc1JkqTUkhrdB-im_knFw6Oom97bHySVIfn6vPDeBVLrk3Ms6QxaULUUMjSwkvQp26aZJonmf11cVkPxkcxZ-P5fEG_OlqYSitspOJtaCelhndkaOTHnPFdWKSD_OfIU2NouhqN0KjIYuRP_uNLlv1fvgRz_c153ufDvuDsJ0qEGZSmEWoRKzQaDAedXM0jRVZSD00S7QSqfMJ2gC5o0Kk1IieSBBiqg3qUDGVvbwXK2p0gCL_WiyQNakyvb9KKcHVul0VqkQTchPpLooq9LsKFaWhFDBKHUMnnq_pwYva4B91eCE-W6u9vTtwu7VX2W5DYHdhwxdbcL2ZYHm2BTcmbWz-Hnzv04dCKt2k9CO07lmZs7YPBMpUVo8DZHiSs7Sk3EXmTtwMrVM2OvVpNaM0LDYv_BIxPXOejb8esC8hgSON34ejK8HyA9gsysI_AubQj_aeR1K6BN253GiVaeXwB7o7aRYFEHWYtFnb2Jzma5zaOsAutG2QbxH5lpBveQBvV4_Mm64elwG_pOOx1C2joHScE7esKjs8-GZ3pUKXTMUmCeBNC5SX-PHMtdUNuAVqsLUGub0GieycrS93VGBbcVLZc-IP4MVqmZ6ksyl8uSQYNHXRezYygIcN9az2xtHopKLrAHY6cjp_-X83_vjyv_Icbg4OJ2M7Hu6PnsAtXtM2XU9tw-bi19I_RWttkT6rWYTBj6vmyb9OVkNA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1da9RAcCgViy9S61ds1VUUQQnN7Wazuw8i5erR89parIU-FNZNblMOSnKaO6R_zV_nTD6uXsG-9fHYSXI7O587XwBvcsm9kXGGLC5diBoaWUp4EerUjZNE8zyrry4ODpO9k_jLqTxdgT9dLQylVXYysRbU4zKjO3J00mOuuE5Msp23aRFHu4NP058hTZCiSGs3TqMhkZG__I3uW_VxuItn_Zbzwefv_b2wnTAQZlKYWahErNCAMB71dDSOFVlLPTRRtBKp8wnaA7mjoqTUiJ5IEGKsDepTMZa9vBcranqA4v-OEkoTj-n-Ir0EV-vWVageTchNpLuIqtDbFSpNQ-lglEaGDj1f0onXNcM_qvFarLZWgYN1uN_armynIbYHsOKLDbjbTLO83IC1gzZO_xDO-vShkMo4KRUJLX1W5qztCYHyldWjARme6iQtKY-RuXM3QUuVjS58Wk0oJYtNCz9HTE-cZ_tHx-xrSOBI74_g5Faw_BhWi7LwT4E59Km955GULkHXLjdaZVo5_IGuT5pFAUQdJm3WNjmnWRsXtg62C20b5FtEviXkWx7A-8Uj06bDx03Ar-l4LHXOKIgGz928quzw-JvdkQrdMxWbJIB3LVBe4scz11Y64Bao2dYS5NYSJLJ2trzcUYFtRUtlrxghgFeLZXqSzqbw5Zxg0OxFT9rIAJ401LPYG0cDlAqwA_jQkdPVy_-78Wc3_5WXsIbcaPeHh6NNuMdr0qabqi1Ynf2a--douM3SFzWHMPhx2yz5Fw8_R3Y |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cross-specificity+of+protective+human+antibodies+against+Klebsiella+pneumoniae+LPS+O-antigen&rft.jtitle=Nature+immunology&rft.au=Rollenske%2C+Tim&rft.au=Szijarto%2C+Valeria&rft.au=Lukasiewicz%2C+Jolanta&rft.au=Guachalla%2C+Luis+M.&rft.date=2018-06-01&rft.pub=Nature+Publishing+Group+US&rft.issn=1529-2908&rft.eissn=1529-2916&rft.volume=19&rft.issue=6&rft.spage=617&rft.epage=624&rft_id=info:doi/10.1038%2Fs41590-018-0106-2&rft.externalDocID=10_1038_s41590_018_0106_2 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1529-2908&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1529-2908&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1529-2908&client=summon |